EU – Baltic States, Good for Business, Lithuania, Markets and Companies, Medicine, Technology
International Internet Magazine. Baltic States news & analytics
Friday, 29.03.2024, 10:35
Biogen establishes subsidiary in Lithuania
BC, Vilnius, 25.06.2020.Print version
Biogen, a US-best biotechnology company, one of the largest in the world, has established a subsidiary in Lithuania and it plans to research, produce, test and sell pharmaceutical and biological products., informs LETA/BNS.
Based on information from the Lithuanian Center of Registers, Biogen Lithuania was registered on June 22 and is led by Finnish citizen Mikko Juhani Fernstroem. The company's shares are owned by Switzerland's Biogen Swiss Investmens, part of the Biogen group.
Biogen posted 14.38 billion US dollars (12.75 billion euros) in revenue last year, up 6.9 percent from the same period last year, with 59 percent of it earned in the US market. The group's net profit rose 31.6 percent to 5.89 billion US dollars (5.22 billion euros).
Other articles:
- 28.01.2022 BONO aims at a billion!
- 26.08.2021 LLC Dizozols Investments finalizes investment attraction deal with Crowdestor with record-high profits
- 13.02.2021 Моя жизнь в газете. Очерки по новейшей истории Латвии. Глава 1
- 30.12.2020 Накануне 25-летия Балтийский курс/The Baltic Course уходит с рынка деловых СМИ
- 30.12.2020 On the verge of its 25th anniversary, The Baltic Course leaves business media market
- 30.12.2020 Business Education Plus предлагает анонсы бизнес-обучений в январе-феврале 2021 года
- 30.12.2020 Hotels showing strong interest in providing self-isolation service
- 30.12.2020 EU to buy additional 100 mln doses of coronavirus vaccine
- 30.12.2020 ЕС закупит 100 млн. дополнительных доз вакцины Biontech и Pfizer
- 29.12.2020 Latvia to impose curfew, state of emergency to be extended until February 7